1. Home
  2. BTOC vs XCUR Comparison

BTOC vs XCUR Comparison

Compare BTOC & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.31

Market Cap

13.5M

Sector

N/A

ML Signal

HOLD

XCUR

Exicure Inc.

HOLD

Current Price

$1.23

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOC
XCUR
Founded
2020
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
13.7M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
BTOC
XCUR
Price
$0.31
$1.23
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
34.8K
35.6K
Earning Date
05-24-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
83.37
EPS
N/A
N/A
Revenue
$190,408,258.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.03
N/A
52 Week Low
$0.23
$1.05
52 Week High
$1.45
$9.48

Technical Indicators

Market Signals
Indicator
BTOC
XCUR
Relative Strength Index (RSI) 56.41 40.67
Support Level $0.25 $1.18
Resistance Level $0.32 $1.48
Average True Range (ATR) 0.02 0.12
MACD 0.00 0.03
Stochastic Oscillator 74.92 47.73

Price Performance

Historical Comparison
BTOC
XCUR

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About XCUR Exicure Inc.

Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.

Share on Social Networks: